Finance
Cancer Prevention
Health
Enochian Biosciences
$4.829876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$4.82
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
+$0.13 (2.77%) Today
$0.00 (0.00%) As of 4:00 PM EDT after-hours
Why Robinhood?
You can buy or sell ENOB and other stocks, options, ETFs, and crypto commission-free!
About ENOB
Enochian Biosciences, Inc. engages in the development of vaccine for treatment of infectious diseases and cancer. Its pipeline consists of ENO-1001, ENO-2001, ENO-3001, ENO-4002 and ENO-4001. Read More The company was founded by Rene Sindlev on January 18, 2011 and is headquartered in Horsholm, Denmark. ENOB is listed on the OTCQB market tier. OTC market data is provided by OTC Markets Group, Inc (otcmarkets.com).
CEO
—
Employees
4
Headquarters
Los Angeles, California
Founded
2011
Market Cap
181.92M
Price-Earnings Ratio
—
Dividend Yield
0.00
Average Volume
37.96K
High Today
$5.07
Low Today
$4.71
Open Price
$5.07
Volume
23.70K
52 Week High
$9.50
52 Week Low
$3.50
Collections
Finance
Cancer Prevention
Health
2018 IPO
US
North America
Price Paid on Robinhood
28% Lower
Right Now
52 Week Low
$3.50
Average Price Paid
$6.73
52 Week High
$9.50
ENOB Earnings
Q4 2018
Q1 2019
Q2 2019
Estimated
—
Actual
Expected Sep 27, Pre-Market